Perspective Therapeutics (CATX) stock: insider trades, news & valuation
Net sellingShare price and insider trades
Perspective Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $42K and 2 sold $1.6M of CATX stock on the open market.
Get emailed when insiders cluster-buy stocks like CATX
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
CATX insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $1.6M | 7 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | $42K | 2 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 2 Perspective Therapeutics, Inc. insiders reported open-market purchases totaling $42K, while 2 insiders reported sales totaling $1.6M. 0 of 7 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 8SEC | Lantheus Alpha Therapy, Llc10% Owner | Sell | 167,14911,273,364 held (−1%) | $3.15 | $527K | -15.6% | — |
| Sep 8SEC | Lantheus Alpha Therapy, Llc10% Owner | Sell | 80,78311,440,513 held (−1%) | $3.11 | $251K | -14.5% | — |
| Sep 4SEC | Lantheus Alpha Therapy, Llc10% Owner | Sell | 78,14511,599,194 held (−1%) | $3.14 | $245K | -15.3% | — |
| Sep 4SEC | Lantheus Holdings, Inc.10% Owner | Sell | 42,12911,521,296 held (−0%) | $3.11 | $131K | -14.5% | — |
| Sep 4SEC | Lantheus Alpha Therapy, Llc10% Owner | Sell | 35,76911,563,425 held (−0%) | $3.12 | $112K | -14.7% | — |
| Sep 3SEC | Lantheus Holdings, Inc.10% Owner | Sell | 35,76911,563,425 held (−0%) | $3.12 | $112K | -14.7% | — |
| Sep 2SEC | Lantheus Holdings, Inc.10% Owner | Sell | 78,14511,599,194 held (−1%) | $3.14 | $245K | -15.3% | — |
| Nov 17SEC | Jonathan Robert HuntChief Accounting Officer | Buy | 11,00059,800 held (+23%) | $2.03 | $22K | +31.0% | — |
| Nov 14SEC | Robert F Williamson IIIDirector | Buy | 9,4989,864 held (+2595%) | $2.10 | $20K | +26.7% | — |
Insiders at Perspective Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Lantheus Alpha Therapy, Llc10% Owner | — | $1.1M | Sep 8, 2026 | — |
| Lantheus Holdings, Inc.10% Owner | — | $488K | Sep 4, 2026 | — |
| Jonathan Robert HuntChief Accounting Officer | $22K | — | Nov 17, 2025 | — |
| Robert F Williamson IIIDirector | $20K | — | Nov 14, 2025 | — |
CATX stock: common questions
Are Perspective Therapeutics, Inc. insiders buying CATX stock?
In the past 12 months, 2 insiders reported open-market purchases of CATX worth $42K. The latest was Chief Accounting Officer Jonathan Robert Hunt bought $22K of CATX at $2.03 — first open-market purchase in our records; raises the stake by 23%.
Are Perspective Therapeutics, Inc. insiders selling CATX stock?
2 insiders reported sales worth $1.6M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is CATX's 52-week range?
Over the past year CATX has traded between $2.05 and $5.65. It last closed at $2.66 on Oct 9, 2026.